Dynamic changes of serum Clara cell protein and surfactant protein-D in rats with pulmonary fibrosis and their value in early diagnosis
10.3760/cma.j.issn.1008-6315.2010.06.002
- VernacularTitle:肺纤维化大鼠血清克拉拉细胞蛋白和表面活性蛋白-D动态变化及早期诊断意义
- Author:
Hongyang WANG
;
Lili LI
;
Hongli WANG
;
Yuping BAI
;
Qingzhao LI
;
Heliang LIU
- Publication Type:Journal Article
- Keywords:
Pulmonary fibrosis;
Clara cell protein;
Surfactant protein-D
- From:
Clinical Medicine of China
2010;26(6):564-566
- CountryChina
- Language:Chinese
-
Abstract:
Objective To detect the dynamic changes of the level of serum Clara cell protein(CC16)and surfactant protein-D(SP-D)in rats with pulmonary fibrosis induced by bleomycin and to evaluate their value in early diagnosis of pulmonary fibrosis. Methods Sixty Wistar rats were randomly divided into two groups, the control group and bleocin-induced pulmonary fibrotic group,with 30 rats in each group. The rats were killed at 1,3,7,14 and 28 days of treatment Pathology changes of lung tissue were observed by HE,Masson stain,alkaline hydrolysis to assess the hydroxyproline concentration of lung tissue, enzyme-linked immunosorbent assay (ELISA) was used to measure the levels of serum CC16 and SP-D. Results The hydroxyproline concentration of lung tissue in the pulmonary fibrotic group ((913. 1 ±69. 3) μg/g) were higher than those of the control group ((790. 5 ± 36. 8) μg/g) from the seventh day(P <0. 05). The levels of serum CC16 of the pulmonary fibrotic group((27. 34 ± 0. 32) μg/L) were lower than those of the control group((27. 85 ±0. 32)μg/L) since the third day(P<0. 05) ,and tended to decrease with the development of the disease. However,the levels of SP-D of the former group were always higher(P <0. 05), and tended to increase with the development of the disease. Conclusions The levels of serum CC16 and SP-D changed considerably in early-stage of pulmonary fibrosis, thus might be used as biomarker for early diagnosis and have some value for pathogenesis of pulmonary fibrosis.
